Repeating waveform matrix without solid framework structures considerably reduces device stiffness and is comparable to the material stiffness of PEEK.1
FDA cleared proprietary NANOACTIV™ implant surface has been engineered with nano-scale surface features at a nanometer (10-9) level.
Edge-to-edge uniform porosity disperses dynamic loading on the vertebral endplates providing a unique Snowshoe Effect™ that allows bone to adapt to the device.1
neoWave™ consists of a 3D-printed consistent waveform matrix that reduces stiffness and provides a load-dispersing Snowshoe Effect™ to lessen the potential for implant subsidence.1 This uniformly-porous architecture contributes to a device stiffness that is less than cortical bone while increasing bone graft volume and providing a lattice for bone ingrowth.
Strength Under Impaction3
The NANOACTIV™ micro and nano-roughened surface is designed to improve fixation to adjacent bone, and has been engineered with nano-scale surface features at a nanometer (10-9) level, which has demonstrated the ability to elicit an endogenous cellular and biochemical response as represented by differentiation of human mesenchymal stem cells through the osteogenic lineage and production of a mineralized matrix in vitro4, as compared to an untreated surface1.
The NANOACTIV™ implant surface demonstrates elements to be considered a nanotechnology as outlined in FDA nanotechnology guidance document.